Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML).
Aquaporins (AQPs) have previously been associated with increased expression in solid tumors. However, its expression in hematologic malignancies including CML has not been described yet. Here, we report the expression of AQP5 in CML cells by RT-PCR and immunohistochemistry. While normal bone marrow...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2008
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/0cf4ab838fd34b01827fcbe74e5db4bd |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:0cf4ab838fd34b01827fcbe74e5db4bd |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:0cf4ab838fd34b01827fcbe74e5db4bd2021-11-25T06:11:43ZHuman AQP5 plays a role in the progression of chronic myelogenous leukemia (CML).1932-620310.1371/journal.pone.0002594https://doaj.org/article/0cf4ab838fd34b01827fcbe74e5db4bd2008-07-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18612408/?tool=EBIhttps://doaj.org/toc/1932-6203Aquaporins (AQPs) have previously been associated with increased expression in solid tumors. However, its expression in hematologic malignancies including CML has not been described yet. Here, we report the expression of AQP5 in CML cells by RT-PCR and immunohistochemistry. While normal bone marrow biopsy samples (n = 5) showed no expression of AQP5, 32% of CML patient samples (n = 41) demonstrated AQP5 expression. In addition, AQP5 expression level increased with the emergence of imatinib mesylate resistance in paired samples (p = 0.047). We have found that the overexpression of AQP5 in K562 cells resulted in increased cell proliferation. In addition, small interfering RNA (siRNA) targeting AQP5 reduced the cell proliferation rate in both K562 and LAMA84 CML cells. Moreover, by immunoblotting and flow cytometry, we show that phosphorylation of BCR-ABL1 is increased in AQP5-overexpressing CML cells and decreased in AQP5 siRNA-treated CML cells. Interestingly, caspase9 activity increased in AQP5 siRNA-treated cells. Finally, FISH showed no evidence of AQP5 gene amplification in CML from bone marrow. In summary, we report for the first time that AQP5 is overexpressed in CML cells and plays a role in promoting cell proliferation and inhibiting apoptosis. Furthermore, our findings may provide the basis for a novel CML therapy targeting AQP5.Young Kwang ChaeSung Koo KangMyoung Sook KimJanghee WooJuna LeeSteven ChangDong-Wook KimMyungshin KimSeonyang ParkInho KimBhumsuk KeamJiyoung RheeNam Hee KooGyeongsin ParkSoo-Hyun KimSe-Eun JangIl-Young KweonDavid SidranskyChulso MoonPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 3, Iss 7, p e2594 (2008) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Young Kwang Chae Sung Koo Kang Myoung Sook Kim Janghee Woo Juna Lee Steven Chang Dong-Wook Kim Myungshin Kim Seonyang Park Inho Kim Bhumsuk Keam Jiyoung Rhee Nam Hee Koo Gyeongsin Park Soo-Hyun Kim Se-Eun Jang Il-Young Kweon David Sidransky Chulso Moon Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML). |
| description |
Aquaporins (AQPs) have previously been associated with increased expression in solid tumors. However, its expression in hematologic malignancies including CML has not been described yet. Here, we report the expression of AQP5 in CML cells by RT-PCR and immunohistochemistry. While normal bone marrow biopsy samples (n = 5) showed no expression of AQP5, 32% of CML patient samples (n = 41) demonstrated AQP5 expression. In addition, AQP5 expression level increased with the emergence of imatinib mesylate resistance in paired samples (p = 0.047). We have found that the overexpression of AQP5 in K562 cells resulted in increased cell proliferation. In addition, small interfering RNA (siRNA) targeting AQP5 reduced the cell proliferation rate in both K562 and LAMA84 CML cells. Moreover, by immunoblotting and flow cytometry, we show that phosphorylation of BCR-ABL1 is increased in AQP5-overexpressing CML cells and decreased in AQP5 siRNA-treated CML cells. Interestingly, caspase9 activity increased in AQP5 siRNA-treated cells. Finally, FISH showed no evidence of AQP5 gene amplification in CML from bone marrow. In summary, we report for the first time that AQP5 is overexpressed in CML cells and plays a role in promoting cell proliferation and inhibiting apoptosis. Furthermore, our findings may provide the basis for a novel CML therapy targeting AQP5. |
| format |
article |
| author |
Young Kwang Chae Sung Koo Kang Myoung Sook Kim Janghee Woo Juna Lee Steven Chang Dong-Wook Kim Myungshin Kim Seonyang Park Inho Kim Bhumsuk Keam Jiyoung Rhee Nam Hee Koo Gyeongsin Park Soo-Hyun Kim Se-Eun Jang Il-Young Kweon David Sidransky Chulso Moon |
| author_facet |
Young Kwang Chae Sung Koo Kang Myoung Sook Kim Janghee Woo Juna Lee Steven Chang Dong-Wook Kim Myungshin Kim Seonyang Park Inho Kim Bhumsuk Keam Jiyoung Rhee Nam Hee Koo Gyeongsin Park Soo-Hyun Kim Se-Eun Jang Il-Young Kweon David Sidransky Chulso Moon |
| author_sort |
Young Kwang Chae |
| title |
Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML). |
| title_short |
Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML). |
| title_full |
Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML). |
| title_fullStr |
Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML). |
| title_full_unstemmed |
Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML). |
| title_sort |
human aqp5 plays a role in the progression of chronic myelogenous leukemia (cml). |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2008 |
| url |
https://doaj.org/article/0cf4ab838fd34b01827fcbe74e5db4bd |
| work_keys_str_mv |
AT youngkwangchae humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT sungkookang humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT myoungsookkim humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT jangheewoo humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT junalee humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT stevenchang humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT dongwookkim humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT myungshinkim humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT seonyangpark humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT inhokim humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT bhumsukkeam humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT jiyoungrhee humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT namheekoo humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT gyeongsinpark humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT soohyunkim humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT seeunjang humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT ilyoungkweon humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT davidsidransky humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml AT chulsomoon humanaqp5playsaroleintheprogressionofchronicmyelogenousleukemiacml |
| _version_ |
1718414024992882688 |